IperionX Limited (IPX) Income Statement
IPX FY2026 at a glance
Fiscal year ended June 30, 2026 · U.S. dollarsIPX revenue and net income
IPX growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
IPX quarterly EPS vs estimates
IperionX beat the analyst EPS estimate in 5 of the last 8 quarters.
IPX income statement
| FY2026 | FY2025 | FY2024 | FY2017 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $4.4M | $2.3M | $648,218 | — |
| Gross profit | −$4.4M | −$2.3M | −$648,218 | — |
| Research & development | $21.6M | $12.7M | $8.9M | — |
| Sales, general & admin | — | $25.5M | $13.5M | — |
| Total operating expenses | $65.7M | $38.3M | $22.4M | $73,553 |
| Operating income | −$70.0M | −$39.3M | −$22.5M | −$73,555 |
| Interest income | — | — | $546,029 | — |
| Interest expense | $3.5M | $305,729 | $90,378 | — |
| Income before taxes | −$67.1M | −$35.3M | −$21.8M | −$73,553 |
| Income taxes | — | — | −$382,415 | −$40,200 |
| Net income | −$67.1M | −$35.3M | −$22.2M | −$73,553 |
| EBITDA | −$65.7M | −$37.0M | −$22.0M | −$73,555 |
| EPS (diluted) | −$0.25 | −$0.12 | −$0.05 | −$0.01 |
| Jun '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $2.4M | $2.0M | $728,184 | $728,184 | — | $1.5M | $353,279 | $353,279 | — | $294,677 | — | $275,290 |
| Gross profit | −$2.4M | −$2.0M | −$728,184 | −$728,184 | — | −$1.5M | −$353,279 | −$353,279 | — | −$294,677 | — | −$275,290 |
| Research & development | $14.5M | $10.8M | $12.7M | $12.7M | $2,969 | $6,808 | $3,404 | $2,474 | $2,474 | $1,881 | $1,882 | $1,751 |
| Sales, general & admin | — | — | $26.5M | $14.1M | $4,314 | $13,732 | $2,715 | $3,773 | $2,185 | $3,178 | $1,895 | $2,741 |
| Total operating expenses | $30.8M | $34.7M | $39.3M | $39.3M | $9,364 | $20,542 | $10,271 | $12.1M | $6,248 | $5,060 | $5,322 | $4,470 |
| Operating income | −$33.2M | −$36.7M | −$18.7M | $1.7M | −$9,364 | −$20.5M | −$10,271 | −$6,248 | −$6,248 | −$10.2M | −$5,060 | −$4,492 |
| Interest expense | $2.0M | $1.4M | $1,323 | $1,323 | — | $304,406 | $61,066 | $61,066 | — | $62,120 | — | $56,982 |
| Income before taxes | −$32.1M | −$34.8M | −$19.1M | −$35.3M | −$9,555 | −$16,236 | −$8,118 | −$5,674 | −$5,674 | −$10.6M | −$5,248 | −$4,345 |
| Income taxes | — | — | — | — | — | — | $11.3M | $11.3M | — | $3 | −$43,232 | −$43,768 |
| Net income | −$32.1M | −$34.8M | −$35.3M | −$35.3M | −$9,555 | −$16,236 | −$8,118 | −$5,674 | −$5,674 | −$5,247 | −$5,248 | −$4,345 |
| EBITDA | −$30.8M | −$34.7M | −$37.7M | −$37.8M | −$8,812 | $752,557 | −$10,081 | −$6,217 | −$6,204 | −$5,015 | −$5,016 | −$4,483 |
| EPS (diluted) | — | $0.00 | −$0.25 | −$0.06 | $0.00 | −$0.06 | $0.00 | −$0.05 | — | — | — | $0.00 |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IPX's financial statements (latest annual report filed September 29, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
IPX financial results
IperionX reported no revenue in fiscal year 2026 (ended June 30, 2026). It had a net loss of $67.1 million. Diluted earnings per share came to −$0.25.
See the IPX stock overview for the latest quote and news, or the IPX chart for price history and technical indicators.
IPX income statement FAQ
Does IperionX have revenue?
IperionX reported no revenue for fiscal year 2026, which ended on June 30, 2026.
Is IperionX profitable?
No. IperionX reported a net loss of $67.1 million in fiscal 2026.
How much does IperionX spend on research and development?
IperionX spent $21.6 million on research and development in fiscal 2026.
What are IperionX's earnings per share?
IperionX earned $-0.25 per diluted share in fiscal 2026, compared with $-0.12 a year earlier.
When does IperionX's fiscal year end?
IperionX's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026 and was filed on September 29, 2026.